Medicare to screen seniors for Alzheimer's, targeting health disparities
H.R. 3501 — To amend title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination. · Filed by Linda Sánchez (D-CA) · 31 cosponsors · Introduced May 19, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicare to include cognitive impairment screening (using tools approved by the National Institute on Aging) as part of the annual wellness visit and initial preventive physical exam for seniors, starting January 1, 2026. The screening results must be documented in the patient's medical record. The bill aims to catch early signs of Alzheimer's and dementia so patients can access treatment and care planning sooner.
Why we flagged it
The bill is a straightforward preventive health measure that mandates cognitive screening in existing Medicare preventive visits. It is not a tax provision, appropriation, or regulatory carve-out—it is a clinical practice requirement tied to public health evidence.
What the text implies
- Screening mandate may increase Medicare claims volume and reimbursement for cognitive assessment services, benefiting diagnostic testing providers and neuropsychology practices.
- Early detection could drive downstream demand for Alzheimer's disease treatments (monoclonal antibodies, other therapeutics), indirectly benefiting pharmaceutical manufacturers.
The full analysis lists 4 implications of this text.
Who stands to gain
diagnostic testing providers; neuropsychology practices; pharmaceutical companies (Alzheimer's therapeutics)